ROS1 and non-small cell lung carcinoma: Because of the rarity, the sample size was relatively small, and a comparative analysis elucidating the difference in CT findings between NSCLC with METex14 skipping and those with other rare driver oncogenes, such as ROS1, BRAF and RET, could not be performed.